1. Endothelial dysfunction and cardiometabolic diseases: Role of long non-coding RNAs
   Hai-Jian Sun et al, 2016, Life Sciences CrossRef
2. Upregulated miR‑203a‑3p and its potential molecular mechanism in breast cancer: A study based on bioinformatics analyses and a comprehensive meta‑analysis
   Kai‑Teng Cai et al, 2018, Molecular Medicine Reports CrossRef
3. Long noncoding RNAs as novel players in the pathogenesis of hypertension
   Xiaoying Jiang et al, 2020, Hypertension Research CrossRef
4. Identification of Hypothalamic Long Noncoding RNAs Associated with Hypertension and the Behavior/Neurological Phenotype of Hypertensive ISIAH Rats
   Larisa A. Fedoseeva et al, 2022, Genes CrossRef
5. Noncoding RNAs in Hypertension
   Amela Jusic et al, 2019, Hypertension CrossRef
6. The role of long non-coding RNAs in the development of adipose cells
   Albert Sufianov et al, 2023, Non-coding RNA Research CrossRef
7. LncRNA-H19 acts as a ceRNA to regulate HE4 expression by sponging miR-140 in human umbilical vein endothelial cells under hyperglycemia with or without α-Mangostin
   Yanli Luo et al, 2019, Biomedicine & Pharmacotherapy CrossRef
8. Epigenetic mechanisms underlying the benefits of flavonoids in cardiovascular health and diseases: are long non-coding RNAs rising stars?
   Yang Jiang et al, 2022, Critical Reviews in Food Science and Nutrition CrossRef
9. Recent Advances of LncRNA H19 in Diabetes
   Ye Bi et al, 2022, Hormone and Metabolic Research CrossRef
10. LncRNAs and circular RNAs as endothelial cell messengers in hypertension: mechanism insights and therapeutic potential
    Ji-Ru Zhang et al, 2020, Molecular Biology Reports CrossRef
11. A Guide to the Short, Long and Circular RNAs in Hypertension and Cardiovascular Disease
    Priscilla R. Prestes et al, 2020, International Journal of Molecular Sciences CrossRef